Abstract
Commentary to:
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo
Daniel Cejka, Matthias Preusser, Adelheid Woehrer, Wolfgang Sieghart, Sabine Strommer, Johannes Werzowa, Thorsten Fuereder and Volker Wacheck